Mackenzie Financial Corp Ampio Pharmaceuticals, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.16 - $0.47 $1,675 - $4,920	-10,470 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $459 - $1,402	-820 Reduced 7.26%	10,470 $6,000
Q3 2021 Nov 08, 2021	BUY	$1.21 - $1.8 $13,660 - $20,322	11,290 New	11,290 $19,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.